VRS
INDV icon

Virginia Retirement Systems’s Indivior Pharmaceuticals INDV Stock Holding History

Virginia Retirement Systems’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Sell
81,200
-300
-0.4% -$10.9K 0.02% 415
2026
Q1 		$2.48M Buy
81,500
+60,300
+284% +$1.99M 0.02% 389
2025
Q4 		$761K Buy
21,200
+700
+3% +$21.4K ﹤0.01% 668
2025
Q3 		$494K Buy
+20,500
New +$429K ﹤0.01% 756

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virginia Retirement Systems's INDV Position: Q2 2026 in Review

Virginia Retirement Systems reduced its Indivior Pharmaceuticals (INDV) stake by 0.37% in Q2 2026, selling an estimated $10.9K and leaving 81,200 shares worth $3.33M. The position accounts for 0.02% of the portfolio, ranked #415.

Virginia Retirement Systems first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Virginia Retirement Systems held 81,200 shares of Indivior Pharmaceuticals worth $3.33M as of Q2 2026.
  • Virginia Retirement Systems sold 300 Indivior Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
  • Indivior Pharmaceuticals made up 0.02% of Virginia Retirement Systems's portfolio in Q2 2026, its #415 holding.
  • Virginia Retirement Systems first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.